Following that, we examined the association between TAGLN2 expression and the pathological stages of different cancers and found that TAGLN2 expression varied across different stages of BLCA, KICH, KIRC, LIHC, LUSC, PAAD, TGCT, and THCA (Figure 2E), though no significant correlation was observed in other tumor types (Figure S1A). Here, TAGLN2 is linked to neoplasm.